Point72 Hong Kong Ltd - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$169,000
+333.3%
5,978
+242.6%
0.01%
+500.0%
Q2 2022$39,000
-22.0%
1,745
+15.3%
0.00%
-50.0%
Q4 2021$50,000
+127.3%
1,513
+214.6%
0.00%
+100.0%
Q3 2021$22,000
-87.7%
481
-85.2%
0.00%
-83.3%
Q2 2021$179,000
+5.9%
3,253
-16.6%
0.01%
-25.0%
Q4 2020$169,000
-49.9%
3,899
-59.5%
0.01%
-77.8%
Q3 2020$337,000
+1103.6%
9,636
+1011.4%
0.04%
+350.0%
Q3 2019$28,000
+366.7%
867
+588.1%
0.01%
+166.7%
Q4 2018$6,000
-82.9%
126
-69.3%
0.00%
-75.0%
Q2 2018$35,000
-5.4%
410
-9.5%
0.01%
-36.8%
Q1 2018$37,000
+640.0%
453
+409.0%
0.02%
+375.0%
Q4 2017$5,000
-68.8%
89
-63.1%
0.00%
-63.6%
Q3 2017$16,000
-20.0%
241
-39.0%
0.01%
-47.6%
Q2 2017$20,000
+1900.0%
395
+1480.0%
0.02%
+2000.0%
Q1 2017$1,000
-99.3%
25
-99.1%
0.00%
-98.7%
Q3 2016$143,000
+1000.0%
2,700
+800.0%
0.08%
+420.0%
Q2 2016$13,000
+225.0%
300
+200.0%
0.02%
+87.5%
Q1 2016$4,0001000.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders